标题
Novel treatment options for portal hypertension
作者
关键词
-
出版物
Gastroenterology Report
Volume 5, Issue 2, Pages 90-103
出版商
Oxford University Press (OUP)
发表日期
2017-03-14
DOI
10.1093/gastro/gox011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis
- (2017) Rafael Paternostro et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Beta adrenergic blockade and decompensated cirrhosis
- (2017) Thomas Reiberger et al. JOURNAL OF HEPATOLOGY
- The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
- (2017) Philipp Schwabl et al. JOURNAL OF HEPATOLOGY
- A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats
- (2017) Sarai Rodríguez et al. Scientific Reports
- Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
- (2016) P. Schwabl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Novel substituted isoxazole FXR agonists with cyclopropyl, hydroxycyclobutyl and hydroxyazetidinyl linkers: Understanding and improving key determinants of pharmacological properties
- (2016) Olaf Kinzel et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease
- (2016) Emina Halilbasic et al. DIGESTIVE DISEASES
- Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats
- (2016) Shao-Jung Hsu et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Dihydroartemisinin counteracts fibrotic portal hypertensionviafarnesoid X receptor-dependent inhibition of hepatic stellate cell contraction
- (2016) Wenxuan Xu et al. FEBS Journal
- Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis
- (2016) Arpan Mohanty et al. GASTROENTEROLOGY
- Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis
- (2016) Juan G. Abraldes et al. GASTROENTEROLOGY
- Inhibition of epoxyeicosatrienoic acid production in rats with cirrhosis has beneficial effects on portal hypertension by reducing splanchnic vasodilation
- (2016) Marco Di Pascoli et al. HEPATOLOGY
- Liver Capsule: FXR agonists against liver disease
- (2016) Claudia D. Fuchs et al. HEPATOLOGY
- Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
- (2016) Tracey G. Simon et al. HEPATOLOGY
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis
- (2016) Dong Wang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The Guanylyl Cyclase Stlmulator Rloclguat Reduces Liver Fibrosis and Portal Pressure in Cirrhotic Rats
- (2016) P. Schwabl et al. JOURNAL OF HEPATOLOGY
- The Non-Steroidal Fxr Agonist Gs-9674 Reduces Liver Fibrosis and Ameliorates Portal Hypertension in a Rat Nash Model
- (2016) P. Schwabl et al. JOURNAL OF HEPATOLOGY
- Selective Endothelin-A Blockade Decreases Portal Pressure in Patients with Cirrhosis. A Pilot Study Combining a Local Intraarterial and Systemic Administration
- (2016) A. Zipprichi et al. JOURNAL OF HEPATOLOGY
- Noradrenaline Potentiates Portal Hypertension through the Alpha 2a Adrenergic Receptor – A target for Therapy in Portal Hypertension
- (2016) H. Jones et al. JOURNAL OF HEPATOLOGY
- Rivaroxaban Reduces Portal Hypertension in Cirrhotic Rats by Deactivating Hepatic Stellate Cells and Reducing Intrahepatic Microthrombosis
- (2016) M. Vilaseca et al. JOURNAL OF HEPATOLOGY
- Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
- (2016) Denise Oró et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats
- (2016) María Úbeda et al. JOURNAL OF HEPATOLOGY
- Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats
- (2016) Federica Cerini et al. JOURNAL OF HEPATOLOGY
- FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis
- (2016) Len Verbeke et al. Scientific Reports
- Intestinal permeability in a patient with liver cirrhosis
- (2016) Jonathan Manuel Aguirre Valadez et al. Therapeutics and Clinical Risk Management
- Thalidomide Improves the Intestinal Mucosal Injury and Suppresses Mesenteric Angiogenesis and Vasodilatation by Down-Regulating Inflammasomes-Related Cascades in Cirrhotic Rats
- (2016) Tzu-Hao Li et al. PLoS One
- Effects of Sapropterin on Portal and Systemic Hemodynamics in Patients With Cirrhosis and Portal Hypertension: A Bicentric Double-Blind Placebo-Controlled Study
- (2015) Enric Reverter et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats
- (2015) Len Verbeke et al. AMERICAN JOURNAL OF PATHOLOGY
- Activation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation
- (2015) Syeda H. Afroze et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Metformin reduces hepatic resistance and portal pressure in cirrhotic rats
- (2015) Dinesh M. Tripathi et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study
- (2015) Wolfgang Kreisel et al. DIGESTIVE AND LIVER DISEASE
- Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats
- (2015) Dong Wang et al. DIGESTIVE AND LIVER DISEASE
- Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial
- (2015) Priscila Pollo-Flores et al. DIGESTIVE AND LIVER DISEASE
- Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis
- (2015) Sabine Klein et al. GUT
- Attenuated portal hypertension in germ-free mice: Function of bacterial flora on the development of mesenteric lymphatic and blood vessels
- (2015) Sheida Moghadamrad et al. HEPATOLOGY
- Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats
- (2015) Shao-Jung Hsu et al. HEPATOLOGY
- Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats
- (2015) Guillermo Fernández-Varo et al. HEPATOLOGY
- Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension
- (2015) Rajeshwar P. Mookerjee et al. JOURNAL OF HEPATOLOGY
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
- (2015) Brent A Neuschwander-Tetri et al. LANCET
- Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension
- (2015) Johannes Hartl et al. LIVER INTERNATIONAL
- The Use of Nanoparticles to Deliver Nitric Oxide to Hepatic Stellate Cells for Treating Liver Fibrosis and Portal Hypertension
- (2015) Hien T. T. Duong et al. Small
- Thalidomide ameliorates portal hypertensionvianitric oxide synthase independent reduced systolic blood pressure
- (2015) Nicholas G Theodorakis WORLD JOURNAL OF GASTROENTEROLOGY
- Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
- (2015) Frank E. Uschner et al. Scientific Reports
- Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
- (2015) Sabine Klein et al. PLoS One
- A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis
- (2014) Philipp Lutz et al. DIGESTIVE AND LIVER DISEASE
- Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis
- (2014) Mattias Mandorfer et al. GASTROENTEROLOGY
- Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
- (2014) Liu Yang et al. GASTROENTEROLOGY
- Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats
- (2014) Marc Mejias et al. GUT
- KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
- (2014) Giusi Marrone et al. GUT
- Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis
- (2014) Michaela Granzow et al. HEPATOLOGY
- Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats
- (2014) Laura Coch et al. HEPATOLOGY
- Inflammation and portal hypertension – The undiscovered country
- (2014) Gautam Mehta et al. JOURNAL OF HEPATOLOGY
- Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites
- (2014) Ying-Ying Yang et al. JOURNAL OF HEPATOLOGY
- O15 EFFECTS OF THE FXR AGONIST OBETICHOLIC ACID ON HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN ALCOHOLIC CIRRHOSIS: A PROOF OF CONCEPT PHASE 2A STUDY
- (2014) R. Mookerjee et al. JOURNAL OF HEPATOLOGY
- Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats
- (2014) Philipp Schwabl et al. JOURNAL OF HEPATOLOGY
- Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites
- (2014) Diego Rincón et al. LIVER INTERNATIONAL
- The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
- (2014) Fernando J. Barreyro et al. LIVER INTERNATIONAL
- Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets
- (2014) Fan Jiang et al. Nature Reviews Cardiology
- Leptin receptor blockade reduces intrahepatic vascular resistance and portal pressure in an experimental model of rat liver cirrhosis
- (2013) María Gabriela Delgado et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis
- (2013) Josephine A. Grace et al. GASTROENTEROLOGY
- Anticoagulation in patients with liver cirrhosis: complication or therapeutic opportunity?
- (2013) Vipul Jairath et al. GUT
- Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats
- (2013) Eugenio Rosado et al. HEPATOLOGY
- The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus
- (2013) Piero Amodio et al. HEPATOLOGY
- Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats
- (2013) Len Verbeke et al. HEPATOLOGY
- Beneficial effects of dual vascular endothelial growth factor receptor/fibroblast growth factor receptor inhibitor brivanib alaninate in cirrhotic portal hypertensive rats
- (2013) Han-Chieh Lin et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- 593 LENALIDOMIDE AMELIORATES THE PORTAL HYPERTENSIVE SYNDROME IN NON-CIRRHOTIC AND CIRRHOTIC PORTAL HYPERTENSIVE ANIMALS
- (2013) B. Payer et al. JOURNAL OF HEPATOLOGY
- Functional relevance of the cannabinoid receptor 2 — heme oxygenase pathway: A novel target for the attenuation of portal hypertension
- (2013) Christian J. Steib et al. LIFE SCIENCES
- Anti-VEGFR agents ameliorate hepatic venous dysregulation/microcirculatory dysfunction, splanchnic venous pooling and ascites of NASH-cirrhotic rat
- (2013) Ying-Ying Yang et al. LIVER INTERNATIONAL
- Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial
- (2013) Nitin Gupta et al. LIVER INTERNATIONAL
- Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure
- (2013) Mercedes Reboredo et al. PLoS One
- Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis
- (2013) Jin-Hang Gao et al. PLoS One
- Effects of simvastatin on the portal-systemic collateral vascular response to endothelin-1 and shunting degree in portal hypertensive rats
- (2013) Shao-Jung Hsu et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Meta-analysis: the safety and efficacy of vaptans (tolvaptan, satavaptan and lixivaptan) in cirrhosis with ascites or hyponatraemia
- (2012) E. Dahl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Postprandial effects of dark chocolate on portal hypertension in patients with cirrhosis: results of a phase 2, double-blind, randomized controlled trial
- (2012) Andrea De Gottardi et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects of the combined administration of propranolol plus sorafenib on portal hypertension in cirrhotic rats
- (2012) M. D'Amico et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Angiotensin-(1–7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver
- (2012) Chandana B. Herath et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A
- (2012) Valentina Vasina et al. BRITISH JOURNAL OF PHARMACOLOGY
- Rifaximin Improves Systemic Hemodynamics and Renal Function in Patients With Alcohol-Related Cirrhosis and Ascites
- (2012) Georgios N. Kalambokis et al. Clinical Gastroenterology and Hepatology
- Enoxaparin Prevents Portal Vein Thrombosis and Liver Decompensation in Patients With Advanced Cirrhosis
- (2012) Erica Villa et al. GASTROENTEROLOGY
- Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
- (2012) Thomas Reiberger et al. GUT
- Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats
- (2012) Hui-Chun Huang et al. HEPATOLOGY
- Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice
- (2012) Lisheng Zhang et al. HEPATOLOGY
- Interaction between NO and COX pathways modulating hepatic endothelial cells from control and cirrhotic rats
- (2012) Eugenio Rosado et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
- (2012) Jiannis Vlachogiannakos et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats
- (2012) V. Reichenbach et al. JOURNAL OF HEPATOLOGY
- HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
- (2012) Sabine Klein et al. JOURNAL OF HEPATOLOGY
- PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats
- (2012) Aina Rodríguez-Vilarrupla et al. JOURNAL OF HEPATOLOGY
- Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats
- (2012) Maeva Guillaume et al. JOURNAL OF HEPATOLOGY
- Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats
- (2012) Marco Di Pascoli et al. JOURNAL OF HEPATOLOGY
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis
- (2012) Thomas Reiberger et al. JOURNAL OF HEPATOLOGY
- Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
- (2012) Sabine Klein et al. LABORATORY INVESTIGATION
- Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study
- (2012) Moon Young Kim et al. LIVER INTERNATIONAL
- Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling
- (2012) Thomas Reiberger et al. LIVER INTERNATIONAL
- Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat
- (2012) Wei Luo et al. PLoS One
- The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma - a pilot study
- (2011) M. Pinter et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Hemodynamics and pharmacokinetics of tezosentan, a dual endothelin receptor antagonist, in patients with cirrhosis
- (2011) Didier Lebrec et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
- (2011) Guanhua Xie et al. GASTROENTEROLOGY
- Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction
- (2011) L. Moleda et al. GUT
- Dual farnesoid X receptor/TGR5 agonist INT-767 reduces liver injury in the Mdr2 −/− (Abcb4 −/− ) mouse cholangiopathy model by promoting biliary HCO 3− output
- (2011) Anna Baghdasaryan et al. HEPATOLOGY
- Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice
- (2011) Christophe Van Steenkiste et al. HEPATOLOGY
- Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts
- (2011) Jonel Trebicka et al. LIVER INTERNATIONAL
- Reversible Decrease of Portal Venous Flow in Cirrhotic Patients: A Positive Side Effect of Sorafenib
- (2011) Romain Coriat et al. PLoS One
- Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic ratsThis article is one of a selection of papers published in the two-part special issue entitled 20 Years of Endothelin Research.
- (2010) Maria A. Cavasin et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Sildenafil Has No Effect on Portal Pressure but Lowers Arterial Pressure in Patients With Compensated Cirrhosis
- (2010) Puneeta Tandon et al. Clinical Gastroenterology and Hepatology
- Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability
- (2010) Kuei-Chuan Lee et al. CLINICAL SCIENCE
- The Effects of Angiotensin Blocking Agents on the Progression of Liver Fibrosis in the HALT-C Trial Cohort
- (2010) Barham K. Abu Dayyeh et al. DIGESTIVE DISEASES AND SCIENCES
- Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis
- (2010) Pablo Bellot et al. HEPATOLOGY
- Renin–angiotensin–aldosterone inhibitors in the reduction of portal pressure: A systematic review and meta-analysis
- (2010) Puneeta Tandon et al. JOURNAL OF HEPATOLOGY
- Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
- (2010) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats
- (2010) Héctor García-Calderó et al. JOURNAL OF HEPATOLOGY
- Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension
- (2010) Erwin Biecker et al. LIVER INTERNATIONAL
- Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand
- (2010) Jiang Li et al. PLoS One
- Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis
- (2009) J. VLACHOGIANNAKOS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- NCX-1000, a Nitric Oxide–Releasing Derivative of UDCA, Does Not Decrease Portal Pressure in Patients With Cirrhosis: Results of a Randomized, Double-Blind, Dose-Escalating Study
- (2009) Annalisa Berzigotti et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts
- (2009) Peter Fickert et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease
- (2009) Hong-Qiang Feng et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C
- (2009) Jordi Colmenero et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Thalidomide decreases intrahepatic resistance in cirrhotic rats
- (2009) Ying-Ying Yang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Phosphodiesterase-5 inhibitors have distinct effects on the hemodynamics of the liver
- (2009) Leonie Halverscheid et al. BMC GASTROENTEROLOGY
- Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis
- (2009) M Hennenberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin-(1–7), an alternative metabolite of the renin–angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
- (2009) John S. Lubel et al. CLINICAL SCIENCE
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Mouse Model of Portal Hypertension
- (2009) Christophe Van Steenkiste et al. GASTROENTEROLOGY
- Role of β3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis
- (2009) Jonel Trebicka et al. HEPATOLOGY
- Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats
- (2009) Thomas Reiberger et al. JOURNAL OF HEPATOLOGY
- Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis
- (2009) Songwen Zhang et al. JOURNAL OF HEPATOLOGY
- Lack of effect of norfloxacin on hyperdynamic circulation in bile duct-ligated rats despite reduction of endothelial nitric oxide synthase function: result of unchanged vascular Rho-kinase?
- (2009) Martin Hennenberg et al. LIVER INTERNATIONAL
- Norfloxacin treatment for clinically significant portal hypertension: results of a randomised double-blind placebo-controlled crossover trial
- (2009) William Kemp et al. LIVER INTERNATIONAL
- Carbon monoxide produced by intrasinusoidally located haem-oxygenase-1 regulates the vascular tone in cirrhotic rat liver
- (2009) Lien Van Landeghem et al. LIVER INTERNATIONAL
- Inhibition of hepatic tumour necrosis factor-α attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers
- (2009) Ying-Ying Yang et al. LIVER INTERNATIONAL
- The effect of angiotensin-blocking agents on liver fibrosis in patients with hepatitis C
- (2009) Kathleen E. Corey et al. LIVER INTERNATIONAL
- Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis
- (2009) Jian Liang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation
- (2009) Barbara Renga et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Clinical trial: a randomized controlled study on prevention of variceal rebleeding comparing nadolol + ligation vs. hepatic venous pressure gradient-guided pharmacological therapy
- (2008) C. VILLANUEVA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Irbesartan Plus Low-Dose Propranolol Versus Low-Dose Propranolol Alone in Cirrhosis: A Placebo-Controlled, Double-Blind Study
- (2008) Michael Schepke et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Coagulation and fibrosis in chronic liver disease
- (2008) V Calvaruso et al. GUT
- Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension
- (2008) B Lavina et al. GUT
- Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
- (2008) Marc Mejias et al. HEPATOLOGY
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
- (2008) Yan-Dong Wang et al. HEPATOLOGY
- Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats
- (2008) Vasilica Matei et al. JOURNAL OF HEPATOLOGY
- Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis
- (2008) Jens Otto Clemmesen et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Immunolocalization of farnesoid X receptor (FXR) in mouse tissues using tissue microarray
- (2007) Hiroyuki Higashiyama et al. ACTA HISTOCHEMICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started